Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 43 publications
Reply to: Malik MMUD on Early and Sustained Improvements in Sense of Smell With Tezepelumab Treatment in Patients With Chronic Rhinosinusitis With Nasal Polyps (WAYPOINT).
Journal: International forum of allergy & rhinology
Published: July 22, 2026
Lessons learned from clinical trials of thymic stromal lymphopoietin (TSLP) inhibition.
Journal: The Journal of allergy and clinical immunology
Published: May 28, 2026
Real-world effects of asthma biologics on blood eosinophil levels: data from the CHRONICLE study.
Journal: The Journal of asthma : official journal of the Association for the Care of Asthma
Published: April 27, 2026
Reply to: S. N. Katkuri et al. and H. Liu et al. on Early and Sustained Improvements in Sense of Smell With Tezepelumab Treatment in Patients With Chronic Rhinosinusitis With Nasal Polyps (WAYPOINT).
Journal: International forum of allergy & rhinology
Published: April 02, 2026
Thymic stromal lymphopoietin as a therapeutic target for the treatment of eosinophilic esophagitis.
Journal: Clinical and translational gastroenterology
Published: March 27, 2026
Tezepelumab in real-world US patients with severe asthma across phenotypes and underrepresented populations: the phase 4 PASSAGE study.
Journal: American journal of respiratory and critical care medicine
Published: March 18, 2026
Association of Easier Biologic Access with Remission and Other Clinical Outcomes in Severe Asthma: A Global Real-World Study.
Journal: Journal of asthma and allergy
Published: February 10, 2026
Biologic effectiveness increases with earlier biologic initiation after severe asthma onset.
Journal: The journal of allergy and clinical immunology. Global
Published: December 19, 2025
Effectiveness of biologics for reducing occlusive mucus plugs in patients with severe asthma: a systematic review.
Journal: Respiratory research
Published: September 10, 2025
Early and Sustained Improvements in Sense of Smell With Tezepelumab Treatment in Patients With Chronic Rhinosinusitis With Nasal Polyps (WAYPOINT).
Journal: International forum of allergy & rhinology
Published: September 05, 2025
Correction to: Effectiveness and Safety of Tezepelumab in a Diverse Population of US Patients with Severe Asthma: Initial Results of the PASSAGE Study.
Journal: Advances in therapy
Published: July 23, 2025
Effect of tezepelumab on asthma exacerbations co-occurring with infection-attributed acute respiratory illnesses.
Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
Published: June 27, 2025
Last Updated: 09/26/2026